Veracyte PE ratio VCYT

Share price divided by earnings per share over the last twelve months, since 2025.

Today, Oct 23, 2026: 34.2×
Peer median: 42.0×

Veracyte's PE ratio is 34.2× as of Oct 23, 2026: a share price of $47.93 against $1.40 of earnings per share over the last twelve months.

The median for 10 diagnostics and research stocks of a similar size is 42.0×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	34.2×	28.4×	112×
2025	112×	57.3×	125×

Against its peers

Companies in Medical - Diagnostics & Research nearest Veracyte's size, closest first, today.

Company	PE ratio
VCYTVeracyte	34.2×
CDNACareDx	33.4×
BLLNBillionToOne	166×
LNTHLantheus	24.2×
CAICaris Life Sciences	86.5×
BIOBio-Rad Laboratories	44.8×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
NRCNRC Health	87.7×
Peer median	42.0×

Where Veracyte ranks

#6of 20Diagnostics and research stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Veracyte

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.